Characteristics and Impacts of Venous Thromboembolism in Patients with Hepatocellular Carcinoma
- 4 April 2017
- journal article
- research article
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 49 (3) , 275-282
Abstract
Venous thromboembolism (VTE) is a common complication in cancer patients, and is associated with worse prognosis in such population. Hepatocellular carcinoma (HCC) poses high risk for VTE; however, data is scarce regarding the characteristics and consequences of VTE in HCC patients.Keywords
This publication has 41 references indexed in Scilit:
- Current Concepts and Management Approaches in Nonalcoholic Fatty Liver DiseaseThe Scientific World Journal, 2013
- Thrombosis, cancer and renal insufficiency: low molecular weight heparin at the crossroadsSupportive Care in Cancer, 2012
- Venous thromboembolism in patients with cholangiocarcinomaEuropean Journal of Gastroenterology & Hepatology, 2012
- Concomitant and antecedent deep venous thrombosis and cancer survival in male US veteransLeukemia & Lymphoma, 2011
- Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997–2006British Journal of Cancer, 2010
- Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER RegistryHaematologica, 2008
- Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinomaThrombosis Research, 2008
- Venous thromboembolism in patients with diffuse large B-cell lymphomaLeukemia & Lymphoma, 2006
- MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: An explant correlationHepatology, 2003
- Mri Angiography Is Superior to Helical Ct for Detection of Hcc Prior to Liver Transplantation: An Explant CorrelationHepatology, 2003